Intellicell Biosciences, Inc. (OTCMKTS:SVFC) Slides Back as Novelty Wears Out
Predictably, the good days wore out for Intellicell Biosciences, Inc. (OTCMKTS:SVFC), the double-zero stem cell company that rose on a promotion and general optimism. SVFC slid down more than 33% to $0.0049, on selling volumes above $1.67 million. With such a low price, even one day of delay in PR or promotions will cost a lot. 
Investors are becoming more and more impatient with SVFC, as the company has accumulated too much debt, which it did not manage to clear despite the stock dilution. Now, despite the good intentions, SVFC is lining up as an erratic double-zero ticker with little potential to hold onto sufficient volumes. The wild price fluctuations and the slim trading may terminally scare investors away.
The company has given a New York address in an expensive-looking business district, yet it is unknown if the swanky destination will lead to success. Still, in 2012 SVFC announced that it had certified its laboratory with the Biologic Consultant Group, and so at least SVFC has announced a base for further research.
The activity for SVFC started to take off last October, and though the longer-term chart looks flat, there is a clustering of buyers at the beginning of the new year, signaling new hope for the company. But the worries won’t stop unless SVFC ends the money drain and closes up the debt:
- cash: $0
- current assets: $182 thousand
- current liabilities: $10.5 million
- no quarterly revenue
- net loss: $1.8 million
To compare, the star of the stem cell sector, Advanced Cell Technology, Inc. (OTCMKTS:ACTC) is showing some signs of revival, with strong buying volumes on separate days. Still, ACTC is mostly stuck around the 6-cents level.
Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH), another recent hot mover, is still stuck below the penny levels, but at this price could still stage a significant daily run. EAPH is a current exception, since it added medical cannabis treatments to its older stem cell aspirations.
If you still like SVFC, keep in mind that the company holds too many red flags, and plan the size and timing of your investment to minimize losses.
